Please assess the completion status of the following clinical trial:

Trial Title: Naltrexone Implants as Relapse Prevention

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* soon to complete inpatient treatment for opioid addiction~* living in southern Norway~Exclusion Criteria:~* psychosis / major depression, currently not treated~* pregnancy~* liver enzymes: ASAT or ALAT \> threefold above upper boundary~* maintenance treatment with methadone or buprenorphine

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).